Growth hormone treatment for children with growth hormone deficiency
Part of Bones, joints & muscles, Brain & nervous system, Hormones & metabolism clinical trials.
This trial tests a new growth hormone medicine (GB06) for children whose bodies don't make enough growth hormone naturally. The study will see if this treatment helps children grow taller over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Child is between 3–11 years old (boys) or 3–10 years old (girls)
- Child is significantly shorter than average for their age and gender
- Child has been diagnosed with growth hormone deficiency by specific blood tests within the past year
- Child has not received growth hormone treatment before
- Child has normal intelligence and is at early puberty stage (Tanner stage I)
- Child does not have other conditions that affect growth, such as Turner syndrome, diabetes, or serious infections like hepatitis
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new growth hormone injection (GB08) for children who are not growing well because of a condition called growth hormone deficiency. It aims to see if the medicine is safe and helps them grow taller.
This study looks at whether consistently taking growth hormone (Norditropin) helps children reach a height goal by “near final height.” It focuses on children who are short due to growth hormone deficiency or born small for gestational age.
This trial tests a new medicine called LUM-201 for children who haven't grown enough because their bodies don't make enough growth hormone. It aims to help kids who haven't been treated before and are still at an early stage of puberty.
This trial tests if two different ways of making the same medicine (PEG-rhGH) work equally well in healthy men. It helps show the medicine is made consistently.
This study tests a new growth hormone treatment called GenSci134 for children who have not yet gone through puberty and are not growing because their bodies do not make enough growth hormone. The goal is to see if the medicine helps them grow taller.
This trial studies how different types of growth hormone treatment affect growth and metabolism in children with growth hormone deficiency. It helps compare standard treatment with a long-acting type and looks at growth and metabolic changes.
Hear when a new Growth Hormone Deficiency in Children trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.